AU2001247878A1 - Anti-idiotype inducing antibodies, comprising at least one epitope from angiogenin, for the inhibition of angiogenesis - Google Patents

Anti-idiotype inducing antibodies, comprising at least one epitope from angiogenin, for the inhibition of angiogenesis

Info

Publication number
AU2001247878A1
AU2001247878A1 AU2001247878A AU4787801A AU2001247878A1 AU 2001247878 A1 AU2001247878 A1 AU 2001247878A1 AU 2001247878 A AU2001247878 A AU 2001247878A AU 4787801 A AU4787801 A AU 4787801A AU 2001247878 A1 AU2001247878 A1 AU 2001247878A1
Authority
AU
Australia
Prior art keywords
angiogenin
idiotype
angiogenesis
epitope
inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001247878A
Inventor
Ronald Martin Burch
Daniel Andrew Soltis
Zhengyi Jenny Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Publication of AU2001247878A1 publication Critical patent/AU2001247878A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/10—Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU2001247878A 2000-04-05 2001-03-28 Anti-idiotype inducing antibodies, comprising at least one epitope from angiogenin, for the inhibition of angiogenesis Abandoned AU2001247878A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19472900P 2000-04-05 2000-04-05
US60194729 2000-04-05
PCT/US2001/010115 WO2001081579A1 (en) 2000-04-05 2001-03-28 Anti-idiotype inducing antibodies, comprising at least one epitope from angiogenin, for the inhibition of angiogenesis

Publications (1)

Publication Number Publication Date
AU2001247878A1 true AU2001247878A1 (en) 2001-11-07

Family

ID=22718702

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001247878A Abandoned AU2001247878A1 (en) 2000-04-05 2001-03-28 Anti-idiotype inducing antibodies, comprising at least one epitope from angiogenin, for the inhibition of angiogenesis

Country Status (2)

Country Link
AU (1) AU2001247878A1 (en)
WO (1) WO2001081579A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR079217A1 (en) * 2009-11-30 2012-01-04 Genentech Inc COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TUMOR TREATMENT

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL143100A0 (en) * 1998-11-13 2002-04-21 Euro Celtique Sa Contraceptive antibody vaccines

Also Published As

Publication number Publication date
WO2001081579A8 (en) 2002-04-18
WO2001081579A1 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
TR200002230A3 (en) Process for the preparation of epoxides from olefins
HK1057362A1 (en) Integrated process for the preparation of olefin oxides.
HK1050254A1 (en) Isolated instructions for isolated execution.
HK1048122A1 (en) Method for the preparation of citalopram.
AU3276802A (en) Background of the invention
ZA200108855B (en) Method for the preparation of citalopram.
ZA200108854B (en) Method for the preparation of citalopram.
ZA200006996B (en) Method for the regenaration of sorbent materials.
HK1047086A1 (en) Method for the preparation of citalopram.
ZA200206699B (en) Method for the preparation of citalopram.
ZA200110179B (en) Process for the preparation of pure citalopram.
PL356561A1 (en) Process for the epoxidation of olefins
NO20023928L (en) Process for the preparation of citalopram
NO20040027L (en) Process for the preparation of escitalopram
MXPA03004030A (en) Process for the preparation of latent antithrombin iii.
ZA200403432B (en) Method for the preparation of escitalopram.
HK1052702A1 (en) Method for the preparation of 5-carboxyphthalide.
NO20041200L (en) Process for the preparation of citalopram.
PL359560A1 (en) Process for the isolation of lovastatin
PL358336A1 (en) Method for the epoxidation of hydrocarbons
AU2002356180A1 (en) Methods for inhibiting angiogenesis
HK1070357A1 (en) Process for the preparation of 5-substituted isobenzofurans
MXPA02006102A (en) Process for the preparation of bromodifluoroacetic compounds.
MXPA03001577A (en) Method for the isomerisation of allyl alcohols.
AU2001247878A1 (en) Anti-idiotype inducing antibodies, comprising at least one epitope from angiogenin, for the inhibition of angiogenesis